Therapeutic effects of intranasally-administered insulin in adults with amnestic mild cognitive impairment (aMCI) or mild Alzheimer?s disease (AD)
M
Martin Farlow, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this research study is to evaluate whether a type of insulin (Humulin? R) improves memory when administered intranasally (as a ?nasal spray?) to adults with a mild memory impairment or early Alzheimer?s disease.
Description
The purpose of this research study is to evaluate whether a type of insulin (Humulin? R) improves memory when administered intranasally (as a ?nasal spray?) to adults with a mild memory impairment or early Alzheimer?s disease.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
amnestic mild cognitive impairment (aMCI) or mild Alzheimer?s disease (AD)
-
Age: Between 55 Years - 85 Years
-
Gender: All
Updated on
19 Apr 2024.
Study ID: 1309371609
